Home/Filings/4/0001140361-23-003181
4//SEC Filing

Cummings Keith Lamont 4

Accession 0001140361-23-003181

CIK 0001746473other

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 7:15 PM ET

Size

6.8 KB

Accession

0001140361-23-003181

Insider Transaction Report

Form 4
Period: 2023-01-25
Cummings Keith Lamont
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-01-25+76,20076,200 total
    Exercise: $34.65Exp: 2033-01-24Common Stock (76,200 underlying)
  • Award

    Common Stock

    2023-01-25+54,000138,424 total
Footnotes (2)
  • [F1]These are restricted stock units that vest in three equal annual installments beginning January 16, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.
  • [F2]1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.

Documents

1 file

Issuer

PLIANT THERAPEUTICS, INC.

CIK 0001746473

Entity typeother

Related Parties

1
  • filerCIK 0001809204

Filing Metadata

Form type
4
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 7:15 PM ET
Size
6.8 KB